Drupal.behaviors.print = function(context) {window.print();window.close();}>

Amgen Planning PGx Study to Gain Full Regulatory Approval for Vectibix in US Market

February 09, 2011

Amgen Planning PGx Study to Gain Full Regulatory Approval for Vectibix in US Market

The protocol for the trial, which will study overall survival in Vectibix-treated chemorefractory patients with wild-type KRAS tumors, is currently being reviewed by the FDA.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.

Related Stories